Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.22 USD | +0.31% | +5.23% | -26.48% |
Apr. 17 | Eton Pharmaceuticals, Inc. cancelled the transaction announced on April 15, 2024 | CI |
Apr. 15 | Eton Pharmaceuticals, Inc. announced that it expects to receive $13.125 million in funding | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.48% | 82.46M | |
+3.99% | 70.78B | |
+10.72% | 9.15B | |
-15.34% | 4.84B | |
+34.54% | 4.22B | |
+5.09% | 3.92B | |
+17.13% | 2.55B | |
-24.15% | 2.26B | |
-29.70% | 2.24B | |
+9.09% | 1.92B |
- Stock Market
- Equities
- ETON Stock
- News Eton Pharmaceuticals, Inc.
- Transcript : Eton Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 12, 2022